Patent details
EP3226841 Title: ANTICANCER COMPOSITIONS
Basic Information
- Publication number:
- EP3226841
- PCT Application Number:
- US2015063661
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP158176412
- PCT Publication Number:
- WO2016090098
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTICANCER COMPOSITIONS
- French Title of Invention:
- COMPOSITIONS ANTICANCÉREUSES
- German Title of Invention:
- ANTIKREBSZUSAMMENSETZUNGEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 08/11/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 27/11/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 09/10/2024
- Unitary Effect Registration Date:
- 27/11/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 03/12/2015
- Grant date:
- 09/10/2024
- EP Publication Date:
- 11/10/2017
- PCT Publication Date:
- 09/06/2016
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/10/2024
- EP B1 Publication Date:
- 09/10/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 03/12/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/01/2025
- Name:
- Aragon Pharmaceuticals, Inc.
- Address:
- 800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)
History of Owners
- From:
- 02/10/2024
- To:
- 10/01/2025
- Name:
- Aragon Pharmaceuticals, Inc.
- Address:
- 10990 Wilshire Blvd. Suite 440, Los Angeles, CA 90024, United States (US)
Inventor
1
- Name:
- VAUGHN, Jason Michael
- Address:
- United States (US)
2
- Name:
- HESTER, Dennis Martin
- Address:
- United States (US)
Priority
- Priority Number:
- 14196594
- Priority Date:
- 05/12/2014
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 31/4184; A61P 35/00; A61K 9/14; A61K 9/20;
Publication
European Patent Bulletin
1
- Issue number:
- 202441
- Publication date:
- 09/10/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202444
- Publication date:
- 30/10/2024
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202507
- Publication date:
- 12/02/2025
- Description:
- Change of owner's name or address
4
- Issue number:
- 202451
- Publication date:
- 18/12/2024
- Description:
- Unitary Effect Request Receipt
5
- Issue number:
- 202501
- Publication date:
- 01/01/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|